Review



inhibitor effects  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    MedChemExpress inhibitor effects
    Inhibitor Effects, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inhibitor+effects/AP-18/pmc13001051-64-4-12
    Average 94 stars, based on 3 article reviews
    inhibitor effects - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    other:

    Article Title: TRPA1-kinase axis polarization: Nepetalactone drives pest repulsion and predator attraction via divergent PKC/CaMKII signaling.
    Article Snippet: To assess nepetalactone and inhibitor effects (AP-18: Cat# HY-W014421; HC-030031: Cat# HY-15064; MedChemExpress, China), cohorts of at least twenty females were collected at 0.5, 1, 3, and 6 h post-treatment.

    Article Title: TRPA1-kinase axis polarization: Nepetalactone drives pest repulsion and predator attraction via divergent PKC/CaMKII signaling
    Article Snippet: To assess nepetalactone and inhibitor effects (AP-18: Cat# HY-W014421; HC-030031: Cat# HY-15064; MedChemExpress, China), cohorts of at least twenty females were collected at 0.5, 1, 3, and 6 h post-treatment.



    Similar Products

    94
    MedChemExpress inhibitor effects
    Inhibitor Effects, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inhibitor+effects/AP-18/pmc13001051-64-4-12
    Average 94 stars, based on 1 article reviews
    inhibitor effects - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    86
    International Cardio Corporation immune checkpoint inhibitor associated cardiovascular toxic effects
    Immune Checkpoint Inhibitor Associated Cardiovascular Toxic Effects, supplied by International Cardio Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inhibitor+effects/associated+cardiovascular+checkpoint+effects+immune+inhibitor+toxic/pm42163142-304-0-6
    Average 86 stars, based on 1 article reviews
    immune checkpoint inhibitor associated cardiovascular toxic effects - by Bioz Stars, 2026-09
    86/100 stars
      Buy from Supplier

    94
    TargetMol effective natural inhibitors
    Erianin attenuated UM both in vitro and in vivo. ( A ) Heatmap of natural product screening results in PIG1, OMM2.3, and 92-1 cells upon treatment with DMSO or <t>inhibitors</t> (10 µM) for 3 days ( n = 3). ( B ) The chemical structure of erianin. ( C ) IC 50 of erianin in PIG1, MEL290, 92-1, and OMM2.3 cell lines. ( D ) CCK-8 assay showing cell viability of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). ** P < 0.01, *** P < 0.001, **** P < 0.0001. ( E , F ) A colony formation assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. * P < 0.05, ** P < 0.01. ( G , H ) A Transwell assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. ** P < 0.01, *** P < 0.001; ns, no significance. ( I , J ) Images of eyeballs containing xenografts derived from OMM2.3 cells and statistical analysis of the eyeball weight data ( n = 7). Hematoxylin and eosin staining to evaluate tumor formation. The data are presented as mean ± SD. **** P < 0.0001.
    Effective Natural Inhibitors, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inhibitor+effects/FDA-Approved+Kinase+Inhibitor+Library/pmc12720188-92-2-14
    Average 94 stars, based on 1 article reviews
    effective natural inhibitors - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    90
    TargetMol effective pdgfr inhibitors
    Erianin attenuated UM both in vitro and in vivo. ( A ) Heatmap of natural product screening results in PIG1, OMM2.3, and 92-1 cells upon treatment with DMSO or <t>inhibitors</t> (10 µM) for 3 days ( n = 3). ( B ) The chemical structure of erianin. ( C ) IC 50 of erianin in PIG1, MEL290, 92-1, and OMM2.3 cell lines. ( D ) CCK-8 assay showing cell viability of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). ** P < 0.01, *** P < 0.001, **** P < 0.0001. ( E , F ) A colony formation assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. * P < 0.05, ** P < 0.01. ( G , H ) A Transwell assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. ** P < 0.01, *** P < 0.001; ns, no significance. ( I , J ) Images of eyeballs containing xenografts derived from OMM2.3 cells and statistical analysis of the eyeball weight data ( n = 7). Hematoxylin and eosin staining to evaluate tumor formation. The data are presented as mean ± SD. **** P < 0.0001.
    Effective Pdgfr Inhibitors, supplied by TargetMol, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inhibitor+effects/New+compound+4/pm41236573-83-8-16
    Average 90 stars, based on 1 article reviews
    effective pdgfr inhibitors - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    96
    Selleck Chemicals warburg effect inhibitor 2 deoxyglucose
    Erianin attenuated UM both in vitro and in vivo. ( A ) Heatmap of natural product screening results in PIG1, OMM2.3, and 92-1 cells upon treatment with DMSO or <t>inhibitors</t> (10 µM) for 3 days ( n = 3). ( B ) The chemical structure of erianin. ( C ) IC 50 of erianin in PIG1, MEL290, 92-1, and OMM2.3 cell lines. ( D ) CCK-8 assay showing cell viability of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). ** P < 0.01, *** P < 0.001, **** P < 0.0001. ( E , F ) A colony formation assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. * P < 0.05, ** P < 0.01. ( G , H ) A Transwell assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. ** P < 0.01, *** P < 0.001; ns, no significance. ( I , J ) Images of eyeballs containing xenografts derived from OMM2.3 cells and statistical analysis of the eyeball weight data ( n = 7). Hematoxylin and eosin staining to evaluate tumor formation. The data are presented as mean ± SD. **** P < 0.0001.
    Warburg Effect Inhibitor 2 Deoxyglucose, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inhibitor+effects/2-Deoxy-D-glucose/pmc12628240-60-28-35
    Average 96 stars, based on 1 article reviews
    warburg effect inhibitor 2 deoxyglucose - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    90
    Teva oral effective dual inhibitor of fak/alk
    Erianin attenuated UM both in vitro and in vivo. ( A ) Heatmap of natural product screening results in PIG1, OMM2.3, and 92-1 cells upon treatment with DMSO or <t>inhibitors</t> (10 µM) for 3 days ( n = 3). ( B ) The chemical structure of erianin. ( C ) IC 50 of erianin in PIG1, MEL290, 92-1, and OMM2.3 cell lines. ( D ) CCK-8 assay showing cell viability of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). ** P < 0.01, *** P < 0.001, **** P < 0.0001. ( E , F ) A colony formation assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. * P < 0.05, ** P < 0.01. ( G , H ) A Transwell assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. ** P < 0.01, *** P < 0.001; ns, no significance. ( I , J ) Images of eyeballs containing xenografts derived from OMM2.3 cells and statistical analysis of the eyeball weight data ( n = 7). Hematoxylin and eosin staining to evaluate tumor formation. The data are presented as mean ± SD. **** P < 0.0001.
    Oral Effective Dual Inhibitor Of Fak/Alk, supplied by Teva, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inhibitor+effects/oral+effective+dual+inhibitor+of+fak+alk/pmc12180522-362-8-11
    Average 90 stars, based on 1 article reviews
    oral effective dual inhibitor of fak/alk - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    97
    Gilead Sciences reference aas rendering reduced effectiveness reference approval neuraminidase inhibitors ozeltamivir
    Erianin attenuated UM both in vitro and in vivo. ( A ) Heatmap of natural product screening results in PIG1, OMM2.3, and 92-1 cells upon treatment with DMSO or <t>inhibitors</t> (10 µM) for 3 days ( n = 3). ( B ) The chemical structure of erianin. ( C ) IC 50 of erianin in PIG1, MEL290, 92-1, and OMM2.3 cell lines. ( D ) CCK-8 assay showing cell viability of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). ** P < 0.01, *** P < 0.001, **** P < 0.0001. ( E , F ) A colony formation assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. * P < 0.05, ** P < 0.01. ( G , H ) A Transwell assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. ** P < 0.01, *** P < 0.001; ns, no significance. ( I , J ) Images of eyeballs containing xenografts derived from OMM2.3 cells and statistical analysis of the eyeball weight data ( n = 7). Hematoxylin and eosin staining to evaluate tumor formation. The data are presented as mean ± SD. **** P < 0.0001.
    Reference Aas Rendering Reduced Effectiveness Reference Approval Neuraminidase Inhibitors Ozeltamivir, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inhibitor+effects/Tamiflu/10__53730_slash_ijhs__v9n1__15502-333-23-33
    Average 97 stars, based on 1 article reviews
    reference aas rendering reduced effectiveness reference approval neuraminidase inhibitors ozeltamivir - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology jnk inhibitor effect analysis
    Erianin attenuated UM both in vitro and in vivo. ( A ) Heatmap of natural product screening results in PIG1, OMM2.3, and 92-1 cells upon treatment with DMSO or <t>inhibitors</t> (10 µM) for 3 days ( n = 3). ( B ) The chemical structure of erianin. ( C ) IC 50 of erianin in PIG1, MEL290, 92-1, and OMM2.3 cell lines. ( D ) CCK-8 assay showing cell viability of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). ** P < 0.01, *** P < 0.001, **** P < 0.0001. ( E , F ) A colony formation assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. * P < 0.05, ** P < 0.01. ( G , H ) A Transwell assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. ** P < 0.01, *** P < 0.001; ns, no significance. ( I , J ) Images of eyeballs containing xenografts derived from OMM2.3 cells and statistical analysis of the eyeball weight data ( n = 7). Hematoxylin and eosin staining to evaluate tumor formation. The data are presented as mean ± SD. **** P < 0.0001.
    Jnk Inhibitor Effect Analysis, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/inhibitor+effects/JNK+Inhibitor+V/pm39303918-967-2-23
    Average 93 stars, based on 1 article reviews
    jnk inhibitor effect analysis - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    Image Search Results


    Erianin attenuated UM both in vitro and in vivo. ( A ) Heatmap of natural product screening results in PIG1, OMM2.3, and 92-1 cells upon treatment with DMSO or inhibitors (10 µM) for 3 days ( n = 3). ( B ) The chemical structure of erianin. ( C ) IC 50 of erianin in PIG1, MEL290, 92-1, and OMM2.3 cell lines. ( D ) CCK-8 assay showing cell viability of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). ** P < 0.01, *** P < 0.001, **** P < 0.0001. ( E , F ) A colony formation assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. * P < 0.05, ** P < 0.01. ( G , H ) A Transwell assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. ** P < 0.01, *** P < 0.001; ns, no significance. ( I , J ) Images of eyeballs containing xenografts derived from OMM2.3 cells and statistical analysis of the eyeball weight data ( n = 7). Hematoxylin and eosin staining to evaluate tumor formation. The data are presented as mean ± SD. **** P < 0.0001.

    Journal: Investigative Ophthalmology & Visual Science

    Article Title: Erianin Abrogates Cancerous Vasculogenic Mimicry Through Targeting m 5 C Methylase NSUN2 in Uveal Melanoma

    doi: 10.1167/iovs.66.15.47

    Figure Lengend Snippet: Erianin attenuated UM both in vitro and in vivo. ( A ) Heatmap of natural product screening results in PIG1, OMM2.3, and 92-1 cells upon treatment with DMSO or inhibitors (10 µM) for 3 days ( n = 3). ( B ) The chemical structure of erianin. ( C ) IC 50 of erianin in PIG1, MEL290, 92-1, and OMM2.3 cell lines. ( D ) CCK-8 assay showing cell viability of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). ** P < 0.01, *** P < 0.001, **** P < 0.0001. ( E , F ) A colony formation assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. * P < 0.05, ** P < 0.01. ( G , H ) A Transwell assay was performed to assess the growth of UM cells (OMM2.3 and 92-1) upon erianin treatment ( n = 3). The data are presented as the mean ± SD of experimental triplicates. ** P < 0.01, *** P < 0.001; ns, no significance. ( I , J ) Images of eyeballs containing xenografts derived from OMM2.3 cells and statistical analysis of the eyeball weight data ( n = 7). Hematoxylin and eosin staining to evaluate tumor formation. The data are presented as mean ± SD. **** P < 0.0001.

    Article Snippet: To identify effective natural inhibitors of UM, we first performed natural product library screening (TargetMol L6000) at a concentration of 10 μM for each compound , and DMSO served as the control group.

    Techniques: In Vitro, In Vivo, CCK-8 Assay, Colony Assay, Transwell Assay, Derivative Assay, Staining